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Modulation by verapamil of hormonal action on the Henle's loop of
mice. In order to know the role of cytosolic calcium in the modulation
of the hormone action on sodium chloride transport across the thick
ascending limbs of Henle's loop, we examined whether verapamil, a
blocker of cellular calcium entry, can modulate the effects of arginine
vasopressin (AVP) or glucagon in stimulating transepithelial voltage
(Vt) and cyclic AMP generation in the mouse medullary thick ascending
limb (MAL). The pretreatment of the renal tubule with 5 X 105M
verapamil reduced the Vt stimulated with 200 LU/mliter AVP from 1.7
0.3 mY to 0.4 0.4 mV (N = 7, P < 0.05). The changes in Vt were
well correlated with those of unidirectional Cl flux from the lumen to the
bath. However, verapamil did not influence the Vt stimulated with
103M dibutyril cyclic AMP. The pretreatment of the MAL with 105M
verapamil also inhibited the cyclic AMP generation in the MAL from
72.1 17.9 to 50.6 13.6 fmoles/mm/7 mm (N = 7, P < 0.05) as well
as in the medullary collecting tubule from 147.6 46.6 to 121.2 41.6
fmoles/mm/7 mm (N = 4, P <0.05). The effect of verapamil in inhibiting
the AVP—stimulated cAMP was dose—dependent: the cAMP generation
was inhibited by 28.9 6.8 and 61.1 9,3% with 105M and 104M
verapamil, respectively. When verapamil was added to the medium
simultaneously with AVP, the generation of cyclic AMP was unaf-
fected. The pretreatment of the MAL with 5 x 105M verapamil also
reduced the Vt (from 2.0 0.2 to 0.9 0.4 mV, N = 7, P < 0.05) and
the cAMP generation (from 85.5 17.9 to 70.7 13.4 fmoles/mm/7
mm) stimulated with 106M glucagon. From these observations, we
conclude that verapamil inhibits the actions of AVP and glucagon,
enhancing sodium chloride transport across the MAL mainly by reduc-
ing the generation of cyclic AMP.
the administration of verapamil diminished the antidiuretic
effect of vasopressin.
Recently, it has been firmly established that arginine vaso-
pressin (AVP) contributes to the urine concentrating mecha-
nisms not only by increasing water permeability of the collect-
ing tubule but also by increasing sodium chloride transport
across the medullary thick ascending limbs of Henle's loop
[16—18]. It is unknown whether calcium also modulates the
action of vasopressin on the meduilary thick ascending limbs of
Henle's loop (MAL). Recently, it has been shown that various
hormones other than vasopressin including calcitonin, glucagon
and isoproterenol also stimulated sodium chloride transport in
the MAL [19] probably via generation of cAMP [201.
Therefore, in the present study, we examined the effect of
verapamil on vasopressin—stimulated transepithelial voltage
(Vt) and cAMP generation in the mouse MAL. We also exam-
ined whether verapamil modulates the action of glucagon on the
MAL. The results indicate that verapamil diminishes the ac-
tions of vasopressin and of glucagon by decreasing the genera-
tion of cAMP.
Methods
In vitro microperfusion of isolated renal tubules
It has been well established that calcium ion plays an impor-
tant role in the control of various cellular functions. Studies by
anuran membranes [1—9] and mammalian renal tissues [10—12]
have suggested that changes in the level of cytosolic calcium
modulate the hydroosmotic response of these epithelia to
antidiuretic hormone.
Verapamil, a blocker of cellular entry of calcium, has been
used to examine the role of calcium in the modulation of the
action of vasopressin [13—15]. Humes, Simmons and Brenner
[14] reported that in the toad urinary bladder verapamil dimin-
ished the hydroosmotic response to vasopressin but that it
enhanced the response to adenosine-3' ,5'-cyclic monophos-
phate (cAMP). Clearance studies in rats [15] demonstrated that
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Male ddY strain mice weighing 25 to 35g were anesthetized
with pentobarbital (50 mg/kg, i.p.), and both kidneys were
removed. The medullary thick ascending limbs of Henle (MAL)
was isolated from kidney slices without enzymatic treatments.
Isolated renal tubules were perfused in vitro according to the
method of Burg et al [21] with minor modifications. An artificial
solution simulating serum ultrafiltrate in composition was used
for both the dissection medium and perfusion solution. The
composition of the artificial solution was as follows (mM): NaCl
105; KC1 5.0; NaHCO3 25; Na acetate 10; Na2HPO4INaH2PO4
1.0; MgC12 1.0; CaCl2 1.8; D-glucose 8.3 and L-alanine 5.0. The
solution was equilibrated with 95% 02 to 5% Co2 gas. The
transepithelial voltage (Vt) was measured by using an electrom-
eter (Keithley 602, Cleveland, Ohio, USA) connected to a
recorder as described previously [22]. Tubules were perfused at
37°C bubbling with 95% 02 and 5% CO2. Experiments were
started about 20 to 30 mm when the Vt became stable. The
lumen—to—bath 36C1 flux was measured as described previously
[16].
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Cyclic AMP generation in isolated renal tubules
Male ddY strain mice weighing 25 to 35g were anesthetized
with pentobarbital (50 mg/kg i.p.). After a cannula was inserted
into the abdominal aorta, the superior mesenteric artery was
ligated and both kidneys were perfused through the cannula
with 2 to 3 mliter of chilled modified Krebs—Ringer bicarbonate
(KRB) buffer (pH 7.4) containing in mM; NaC1 105, KC1 5.0,
NaHCO3 26, Na acetate 10,Na2HPO4INaH2PO4 1.0, MgC12 1.0,
CaCl2 1.8 and D-glucose 8.3. The buffer was equilibrated with
95% 02 and 5% CO2. This was followed by perfusion with 6 to
7 muter ice—cold KRB buffer containing 8.3 m glucose, 0.9
mg/mliter collagenase (type I, Sigma) and 1 mg/mliter bovine
serum albumin (KRB-BSA-collagenase). The kidneys were
removed and thin slices were made. Then, they were incubated
at 30°C for 30 to 35 mm in KRB-BSA-collagenase bubbling with
95% 02 and 5% CO2.
After the collagenase treatment, the kidney slices were rinsed
with a plain KRB solution. Fragments of the medullary thick
ascending limb (MAL) and medullary collecting tubule (MCT)
were isolated in a cold dissection medium under a stereomicro-
scope. Hanks-HEPES solution (pH 7.4), containing 0.5
mg/mIller BSA, 1 mrivx l-methyl-3-isobutylxanthine (MIX) and
l04M indomethacin, was used for dissection, preincubation
and incubation with test hormones. In initial studies, indometh-
acm was added to avoid the inhibitory effect on the cAMP
formation by prostaglandins. Since the microperfusion studies
were performed in the absence of indomethacin, the cAMP
generation was measured without indomethacin in some exper-
iments. One to four nephron fragments (total length 1 to 3 mm)
were transferred with 10 p.liter of dissection medium and
carefully placed in a plastic tubule. After addition of 10 jiliter
Hanks-HEPES buffer with or without 105M verapamil, sam-
ples were incubated at 37°C for 45 mm. Then, 20 itliter of the
Hanks-HEPES buffer containing appropriate amount of test
hormones was added. The mixture was further incubated at
37°C for seven mm. The incubation were terminated by adding
50 j.diter 0.3M hydrochloric acid. The samples were dried at 35
to 40°C. The samples were kept at —20°C until radioimmuno-
as say. Immediately before assay, 80 tliter of 300 mM imidazole
buffer (pH 6.5) and 20 jsliter of 50 m EDTA (pH 7.4) were
added to each vial and mixed. The generated cAMP was
acetylated and measured by a radioimmunoassay kit (Yamasa
Shoyu, Choshi, Tokyo, Japan). Although this kit uses antibody
to succinyl cAMP, we confirmed that it completely cross—
reacted with acetyl cAMP.
Analysis of the data
In micropertusion studies, the Vt at the end of 15 to 20 mm
period represented the value of a given condition. In studies of
cAMP generation, a mean of triplicated or quadruplicated
samples represented the value of a given condition. Data were
expressed as means SEM. Statistical analysis was performed
by Student's t test for paired samples.
Results
Effects of verapamil on A VP—stimulated Vt of the MAL
Figure 1 summarizes individual data of the experiments in
which we observed the effects of pretreatment with verapamil
on AVP—stimulated Vt of the MAL isolated from the mouse
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Fig. 1. Effect of verapamil on changes in transepithelial voltage (Vt) of
the mouse MAL induced by arginine vasopressin (A VP). The Vt at 15 to
20 mm represented the value of a given condition.
kidney. In the control period of the control experiment (Fig. 1,
left panel), the lumen—positive Vt which was stable for two
periods was demonstrated. The addition of 200 zU/mliter AVP
to the bath caused a significant increase in the Vt. In the
experimental group (Fig. 1, right panel), the Vt was unchanged
at 20 to 30 mm after an addition of 5 x 105M verapamil to the
bath. Under this circumstance, an addition of 200 jzU/mliter
AVP to the bath did not cause a significant increase in the Vt.
To confirm the changes in Vt is associated with the changes in
chloride flux, we measured the unidirectional flux of chloride
from lumen to bath under a similar protocol. Perfusion rates
were not different between both groups (16.80 1.02 vs. 17.03
1.02 nliter/min). The results are summarized in Figure 2. It is
clear that an enhancement of Cl flux with AVP was inhibited by
the pretreatment of the tubules with verapamil. Although the
basal values were slightly higher in the verapamil group than in
the control group, they were not different statistically, indicat-
ing that tubules in both groups were derived from the same
population. These experiments show that verapamil inhibits the
AVP—stimulated Vt as well as the chloride flux in the mouse
MAL.
Effect of verapamil on glucagon-stimulated Vt of the MAL
Figure 3 illustrates individual data of the experiments in
which the effect of verapamil on the glucagon.-stimulated Vt
was observed in the MAL. Addition of l06M glucagon to the
bath caused a significant increase in the Vt (Fig. 3, left panel).
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Fig. 2. Effect of verapamil on the action of arginine vasopressin (AVP)
in increasing chloride flux in the mouse MAL. Each symbol represents
a mean value of three collected samples.
A single administration of 5 x 105M verapamil did not cause
any change in the Vt again (Fig. 3, right panel). Under this
circumstance, an addition of 106M glucagon to the bath did not
cause a significant change in the Vt. These experiments show
that verapamil also inhibits the glucagon—induced Vt in the
mouse MAL.
Effect of verapamil on dibutyryl cAMP (DBcAMP)—stimulated
Vt of the MAL
To define more precisely the mechanism of action of
verapamil, the effect of verapamil on the Vt stimulated with N6,
02-dibutyryl adenosine-3',5'-cyclic monophosphate (DB-
cAMP) was observed. Figure 4 illustrates the individual data.
Addition of 103M DB-cAMP to the bath caused a significant
increase in the Vt (Fig. 4, left panel). After the pre-incubation
with 5 x 105M verapamil, an addition of 103M DB-cAMP to
the bath also caused a significant increase in the Vt (Fig. 4, right
panel). These experiments, therefore, show that verapamil does
not inhibit the DB-cAMP—stimulated Vt in the MAL.
Effect of verapamil on the generation of cAMP stimulated
with AVP in the MAL and MCT
Figure 5 summarizes the results of the experiments in which
effects of verapamil on the generation of the AVP—stimulated
cAMP were observed in the MAL and MCT. An addition of 200
U/mliter AVP to the incubation medium caused a remarkable
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increase in the generation of cAMP in the MAL as well as in the
MCT. After tubules were incubated with 105M verapamil for
45 mm, the AVP—dependent increments in cAMP generation in
both the MAL and MCT were significantly less than the values
in the absence of verapamil pretreatment. The basal levels of
cAMP were very low and were unaffected by verapamil (0.4
0.2 and 1.4 0.9 fmoles/mmI7 mm without and with verapamil,
respectively). These results show that verapamil inhibits the
generation of AVP—stimulated cAMP in both the MAL and
MCT. Since in the perfusion experiments the effect of
verapamil was examined at the concentration of 5 x 105M in
the absence of indomethacine, a dose—dependent effect of
verapamil on the AVP—stimulated cAMP generation was exam-
ined under the similar condition. The AVP—stimulated cAMP
generation was 33.4 8.6 fmoles/mmI7 mm, a value lower than
the value obtained in the presence of indomethacin (72.1 17.9
fmoles/mmJ7 mm). In spite of the lower basal level of cAMP
generation, the percent inhibition was similar when tubules
were pretreated with 105M verapamil (Fig. 6). In four paired
experiments, an increase in verapamil concentration was asso-
ciated with an increase in percent inhibition of AVP—stimulated
cAMP generation (Fig. 6).
In order to examine whether verapamil directly interferes the
binding process of AVP to the receptors, we conducted exper-
iments in which verapamil was added to the incubation medium
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Fig. 3. Effect of verapamil on changes in transepithelial voltage (Vt) of
the mouse MAL induced by glucagon.
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Fig. 4. Effect of verapamil on changes in transepithelial voltage (Vt) of
the mouse MAL induced by dibutyryl cyclic AMP (DR-cAMP).
simultaneously with AVP and the generation of cAMP was
measured in the MAL. Under this experimental condition, the
generation of cAMP stimulated with AVP was unchanged
whether the medium contained verapamil or not (control 46.6
10.2 vs. verapamil experiment 47.6 11.2 fmoles/mmI7 mm, N
= 5). This would indicate that there is a time lag before
verapamil exerts its inhibitory effect on the AVP—stimulated
cAMP generation.
Effect of verapamil on the generation of cAMP stimulated
with glucagon in the MAL
Figure 7 summarizes the results of the experiments in which
the effects of pretreatment with verapamit on the glucagon—
stimulated cAMP generation was observed in the MAL. Addi-
tion of 106M glucagon to the incubation medium caused a
marked increase in cAMP generation in the MAL. When the
renal tubules were preincubated with 105M verapamil for 45
mm, the glucagon—dependent increments in cAMP were also
suppressed.
Discussion
A considerable evidence has accumulated in support of the
view that calcium plays important roles in the hydroosmotic
effect of vasopressin [2, 6—S. 11, 12]. But it is controversial
whether an increase in cytosolic calcium enhances or sup-
presses the action of vasopressin [8]. Yerapamil has been used
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in various experiments as a mean to reduce the cytosolic
calcium ion activity. Although Bentley [131 reported that
verapamil did not inhibit the vasopressin—induced osmotic
water flow across the toad urinary bladder, Humes, Simmons
and Brenner [141 demonstrated that verapamil inhibited the
action of vasopressin in the similar preparation. Renal clear-
ance studies in the rats [151 also demonstrated that verapamil
inhibited the urinary concentrating response to vasopressin.
These data are in support of the view that the inhibition of
calcium entry into epithelia suppresses the hydroosmotic re-
sponse to vasopressin.
It has been also reported that calcium modulates the
natriferic response of the toad urinary bladder to antidiuretic
hormone [8, 10, 23]. Taylor [8] reported that although calcium
ionophores and quinidine inhibited the basal rate of sodium
transport in the toad urinary bladder, they enhanced the
natriferic response to vasopressin. This would suggest that an
increase in cytosolic calcium enhances the natriferic response
to vasopressin. By contrast, Wiesmann et al [231 reported that
the stimulation of sodium transport by a submaximal dose of
vasopressin (10 mU/mliter) was reduced in the ionophore
treated toad bladder. Thus the effect of ionophore on the
natriferic response to vasopressin in the toad urinary bladder
seems to be inconclusive.
In the collecting tubule of the mammalian kidney, vasopres-
sin has the action to stimulate the sodium transport in addition
to the hydroosmotic action [24]. The MAL is unique since
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Fig. 6. Dose—dependent inhibition with verapamil of A VP—stimulated
cAMP generation in the mouse MAL.
vasopressin selectively stimulates the transport of sodium chlo-
ride without affecting water permeability [16—18]. No one has
ever examined whether calcium also modulates the response of
this segment to the stimulation with vasopressin.
The results of our study clearly show that in the mouse MAL
verapamil inhibits the lumen positive voltage stimulated by the
vasopressin, suggesting that the stimulation of sodium chloride
transport with AVP is impaired. Since verapamil had no effect
on the Vt stimulated by DB-cAMP, the effect of verapamil in
modulating the action of vasopressin may not be exerted at the
steps after the generation of cAMP. This notion was confirmed
by the observation that the generation of cAMP after stimula-
tion with vasopression was reduced when the MAL was pretreat-
ed with verapamil. Since verapamil is known to have an
inhibitory effect on cAMP phosphodiesterase [14], verapamil
should have increased rather than decreased cAMP if such a
non-specific effect was predominant. Furthermore, the contri-
bution of such non-specific effect of verapamil was carefully
avoided in our study by adding MIX, a phosphodiesterase
inhibitor, in the incubation medium. However, the possibility
that some steps beyond cAMP generation might be involved
cannot be excluded with certainty for following reason. A high
dose of DB-cAMP used in this study could have overcome
14.8 5.8
(P < 0.05)
Fig. 7. Effect of pretreatment with verapamil on glucagon—stimulated
cyclic AMP generation in the mouse MAL.
minor defects in steps beyond cAMP. From the dose—response
relationship of verapamil in suppressing the AVP-stimulated
cAMP (Fig. 6), 5 x l05M verapamil would be expected to
inhibit the AVP—stimulated cAMP generation by 30 to 60%,
whereas this dose of verapamil almost completely inhibited the
AVP—stimulated Cl transport and Vt (Fig. 2).
One might argue that it is difficult to accept a close correlation
between the changes in cAMP generation and the changes in
physiological responses, at least quantitatively. Such quantita-
tive difference could be partly explained by the following facts.
First, the experimental conditions were not identical between
the physiological and the biochemical studies. The cAMP
generation was measured in collagenase treated tubules without
luminal perfusion in the presence of MIX. Second, the method
that we used as an index of cAMP generation does not always
reflect the intracellular cAMP concentration. For instance, in
the similar preparation, Torikai et al [25] reported that intracel-
lular cAMP reached a maximal value at two mm whereas cAMP
in the medium was further increased at ten mm.
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It is theoretically possible that verapamil might have inter-
acted with vasopres sin at the binding sites of the receptors. But
this possibility may be excluded by the observation that
verapamil had no effect on the generation of cAMP stimulated
with vasopressin when it was added to the incubation medium
simultaneously with vasopressin. It is clear that the preincuba-
tion period is necessary for verapamil to exert its inhibitory
effect on the vasopressin stimulated cAMP. However, in order
to obtain definite evidence, a binding study is necessary.
Although we did not measure intracellular calcium concentra-
tion or calcium fluxes across the cell membranes, it is not
unreasonable to assume that verapamil inhibits the action of
vasopressin by decreasing the entry of calcium into the
cytoplasma of the MAL. The mechanisms by which changes in
intracellular calcium modulate the adenylate cyclase—cAMP
system are unknown. We speculate that verapamil may modu-
late some of the coupling processes between the hormone
receptor and the core enzyme by decreasing cytosolic calcium.
In good agreement with our observations, Ishikawa, Saito
and Yoshida [28] recently reported that the pretreatment with
verapamil of cultured renal papillary tissue decreased the
AVP—stimulated cAMP generation. They further showed that
the treatment of the cultured cells with A23 187, a calcium
ionophore, increased the generation of cAMP stimulated with
AVP. Although their preparation does not consist of cells from
a distinct single nephron segment, it may mainly consist of the
collecting tubule cells. Thus, it is possible that the modulation
of the action of AVP by calcium in the collecting tubule is
similar to that in the MAL, although the final physiological
effects of AVP are quite different between these segments.
Recently, it has been reported that the stimulations of cAMP
in the rat MAL with various hormones are not additive [25, 26].
These observations suggest that several hormones exert the
same function in the MAL through a common adenylate
cyclase—cAMP system. This notion has been partially sup-
ported by functional studies with the micropuncture [27] and
the in vitro microperfusion technique [19]. Our observation that
glucagon increased the Vt of the MAL is in good agreement
with a preliminary report of Culpepper and Andreoli [19]. It is
of interest to note that verapamil also suppressed the changes in
the glucagon induced Vt and generation of cAMP in the mouse
MAL, This would mean that the effect of verapamil is not
confined to the vasopressin—cAMP system at least in the MAL.
On the basis of this study, it is implied that the in vivo effect
of verapamil in suppressing the action of vasopressin [15] is
caused by the action not only on the collecting tubule but also
on the medullary thick ascending limbs. It should be also noted
that verapamil did not influence the basal level of the Vt. This
would suggest that the direct action of calcium antagonists on
the MAL is not responsible for their natriuretic action [29, 30],
supporting the observation of Abe et al [29] that nicardipine, a
calcium antagonist, did not influence the free water absorption
in the dog.
In summary, verapamil reduces the effect of AVP on the
MAL in stimulating transepithelial voltage by affecting some
coupling processes between the hormone receptors and the
core enzyme adenylate cyclase. This process may be common
for other hormonal actions on the MAL mediating the cAMP
system. However, an additional involvement of some steps
beyond cAMP generation can not be excluded.
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